カテゴリ： MarketLine, ドイツ, 企業調査

TUI Group：企業の戦略・SWOT・財務情報

◆英語タイトル：TUI Group - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C4689
◆発行会社（調査会社）：MarketLine
◆発行日：2018年8月
◆ページ数：49
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：ドイツ
◆産業分野：輸送・物流
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

TUI Group – Strategy, SWOT and Corporate Finance Report
Summary

TUI Group – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

TUI Group (TUI) is a tourism company that provides services associated with holiday and travel. The company’s businesses include cruise ships, touristic airlines, tour operation, resorts and hotels, aviation management and incoming agencies. TUI operates hotels under various brands including Riu, Iberotel, TUI Magic Life, Grupotel, TUI Blue and Robinson. It also operates several airlines, including TUI Airways, Corsair International, and TUI fly, among others. It also provides luxury cruises within German-speaking countries, and cruise ships in other luxury market.The company primarily operates in Germany, UK, Ireland, the Nordics, Austria, Poland, Switzerland, Belgium, the Netherlands and France. TUI is headquartered in Hanover, Germany.

Scope

- Detailed information on TUI Group required for business and competitor intelligence needs
- A study of the major internal and external factors affecting TUI Group in the form of a SWOT analysis
- An in-depth view of the business model of TUI Group including a breakdown and examination of key business segments
- Intelligence on TUI Group’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about TUI Group, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of TUI Group and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess TUI Group as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on TUI Group’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
TUI Group: Company Overview 9
TUI Group: Overview and Key Facts 9
TUI Group: Overview 9
TUI Group: Key Facts 9
TUI Group: Key Employees 10
TUI Group: Key Employee Biographies 11
TUI Group: Major Products and Services 13
TUI Group: Company History 14
TUI Group: Management Statement 19
TUI Group: Locations and Subsidiaries 21
TUI Group: Key Competitors 23
TUI Group: Company Analysis 24
TUI Group: Business Description 24
TUI Group: SWOT Analysis 26
TUI Group: SWOT Overview 26
TUI Group: Strengths 26
TUI Group: Weaknesses 27
TUI Group: Opportunities 27
TUI Group: Threats 28
TUI Group: Corporate Financial Deals Activity 30
TUI Group: Financial Deals Overview 30
TUI Group: Targets and Partners 32
TUI Group: Top Deals 2014 – 2018YTD* 33
TUI Group: Advisors 34
TUI Group: Top Legal Advisors 34
TUI Group: Mergers and Acquisitions 35
TUI Group: Corporate Venturing 36
TUI Group: Partnership 37
TUI Group: Divestments 38
TUI Group: Recent Developments 39
TUI Group: News and Events Summary 39
TUI Group: Business Expansion 43
TUI Group: Contracts 44
TUI Group: Regulatory and Legal Events 45
TUI Group: Research & Development 45
TUI Group: Strategy and Operations 45
Appendix 47
Contact Us 47
Methodology 47
About MarketLine 48

List of Tables
Table 1: TUI Group: Key Facts
Table 2: TUI Group: Key Employees
Table 3: TUI Group: Locations and Subsidiaries
Table 4: TUI Group: Key Competitors
Table 5: TUI Group: Deal Activity by Deal Type - Volume (TTM*)
Table 6: TUI Group: M&A Activity by Geography (TTM*)
Table 7: TUI Group: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 8: TUI Group: M&A Average Deal Size - Value (US$m)
Table 9: TUI Group: Targets and Partners
Table 10: TUI Group: Top Deals 2014 - 2018YTD*
Table 11: TUI Group: Legal Advisor Ranking by Value (US$m)
Table 12: TUI Group: M&A Volume and Value Trend (2014 - YTD*2018)
Table 13: TUI Group: M&A Activity by Geography (2014 - YTD*2018)
Table 14: TUI Group: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Table 15: TUI Group: Corporate Venturing by Geography (2014 - YTD*2018)
Table 16: TUI Group: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 17: TUI Group: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 18: TUI Group: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 19: TUI Group: Divestments by Geography (2014 - YTD*2018)
Table 20: TUI Group: News and Events Summary
Table 21: TUI Group: Business Expansion
Table 22: TUI Group: Contracts
Table 23: TUI Group: Regulatory and Legal Events
Table 24: TUI Group: Research & Development
Table 25: TUI Group: Strategy and Operations

List of Figures
Figure 1: TUI Group: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: TUI Group: M&A Activity by Geography (TTM*)
Figure 3: TUI Group: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 4: TUI Group: M&A Average Deal Size - Value (US$m)
Figure 5: TUI Group: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 6: TUI Group: M&A Activity by Geography (2014 - YTD*2018)
Figure 7: TUI Group: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Figure 8: TUI Group: Corporate Venturing by Geography (2014 - YTD*2018)
Figure 9: TUI Group: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 10: TUI Group: Partnership Trend by Deal Type (2014 - YTD*2018)
Figure 11: TUI Group: Divestments Volume and Value Trend (2014 - YTD*2018)
Figure 12: TUI Group: Divestments by Geography (2014 - YTD*2018)

★海外企業調査レポート[TUI Group：企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Xylem Inc (XYL)：石油・ガス：M&Aディール及び事業提携情報
    Summary Xylem Inc (Xylem) is a water technology company. It designs, manufactures, and services engineered solutions ranging across a wide variety of applications. The company’s offerings address customer needs across the water cycle, from the delivery, measurement and use of drinking water to the c …
  • Doppler SA：企業の戦略・SWOT・財務情報
    Doppler SA - Strategy, SWOT and Corporate Finance Report Summary Doppler SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Monex Group, Inc.：企業の戦略・SWOT・財務情報
    Monex Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Monex Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Raia Drogasil SA：企業の戦略・SWOT・財務分析
    Raia Drogasil SA - Strategy, SWOT and Corporate Finance Report Summary Raia Drogasil SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Toleranzia AB-製薬・医療分野：企業M&A・提携分析
    Summary Toleranzia AB (Toleranzia) is a developer of platform technology for the treatment of autoimmune diseases. The company develops and offers products and technologies including Re-Tolerogen for the treatment of autoimmune diseases. Its Re-Tolerogen platform technology is a fusion protein for t …
  • Oncology Venture ApS：製薬・医療：M&Aディール及び事業提携情報
    Summary Oncology Venture ApS (Oncology Venture), a subsidiary of Oncology Venture Sweden AB, is a developer of oncology products. The company offers products in the therapeutic areas of metastatic breast cancer, ovarian cancer, renal cancer, liver cancer, prostate cancer, multiple myeloma, and other …
  • TSO3 Inc (TOS)：医療機器：M&Aディール及び事業提携情報
    Summary TSO3 Inc (TSO3) designs develops, manufactures, markets and licenses sterilization processes for heat-sensitive medical devices. The company’s area of focus is sterile processing, which provides a replacement solution to other low temperature sterilization processes used in hospitals. The co …
  • Osprey Medical Inc (OSP)-医療機器分野：企業M&A・提携分析
    Summary Osprey Medical Inc (Osprey Medical) is a medical device company that designs, develops, and manufacturers proprietary devices and monitoring systems. The company provides contrast removal system, which is designed to provide cardiologists with an advanced level of CIN protection in high risk …
  • Avebe U.A.：企業の戦略的SWOT分析
    Avebe U.A. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Cambridge Cognition Holdings Plc (COG)：医療機器：M&Aディール及び事業提携情報
    Summary Cambridge Cognition Holdings Plc (Cambridge Cognition) is a neuroscience digital health company. The company offers drug development, digital health technology and cognitive research. Its drug development service include enrich clinical trial recruitment, develop safe and effective treatment …
  • Clarivate Plc (CLVT)：企業の財務・戦略的SWOT分析
    Clarivate Plc (CLVT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Nufarm Limited：企業の戦略・SWOT・財務情報
    Nufarm Limited - Strategy, SWOT and Corporate Finance Report Summary Nufarm Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Sumitomo Chemical Co., Ltd.：企業の戦略・SWOT・財務分析
    Sumitomo Chemical Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Sumitomo Chemical Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Clevexel Pharma SAS：製薬・医療：M&Aディール及び事業提携情報
    Summary Clevexel Pharma SAS (Clevexel) is a pharmaceutical company that develops drugs for the treatment of central nervous system diseases. The company’s pipeline product candidate includes CVXL-0107, a glutamate release inhibitor developed to improve the quality of life for Parkinson’s disease pat …
  • Rocky Brands Inc (RCKY)：企業の財務・戦略的SWOT分析
    Rocky Brands Inc (RCKY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Exact Holding N.V.：企業の戦略的SWOT分析
    Exact Holding N.V. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • BL&H Co Ltd-製薬・医療分野：企業M&A・提携分析
    Summary BL&H Co Ltd (BL&H), a subsidiary of STADA Pharmaceuticals (Asia) Ltd is a drug company that manufactures and markets diagnostic test kits and drugs. The company offers products including aridol bronchial challenge test kit, cetraxal plus ear drop, al-sense amniotic leak test kit, DC bead-dru …
  • Intra Energy Corporation Ltd (IEC)：電力：M&Aディール及び事業提携情報
    Summary Intra Energy Corporation Limited (IEC), formerly Atomic Resources Limited, is a mining and energy company that operates through subsidiaries, affiliates, and joint ventures. It explores and mines coal, mineral resources, ore reserves, and uranium through operating interests in various mines. …
  • Melkior Resources Inc. (MKR)：企業の財務・戦略的SWOT分析
    Melkior Resources Inc. (MKR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • ACTIVE Network, LLC：企業のM&A・事業提携・投資動向
    ACTIVE Network, LLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's ACTIVE Network, LLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆